Hostname: page-component-586b7cd67f-tf8b9 Total loading time: 0 Render date: 2024-11-23T21:00:16.187Z Has data issue: false hasContentIssue false
  • English
  • Français

Nosology of atypical depression

Published online by Cambridge University Press:  09 July 2009

E. S. Paykel ,
R. R. Parker ,
P. R. Rowan ,
B. M. Rao  and
C. N. Taylor
E. S. Paykel*
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, London
R. R. Parker
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, London
P. R. Rowan
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, London
B. M. Rao
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, London
C. N. Taylor
Affiliation:
Department of Psychiatry, St George's Hospital Medical School, London
*
1Address for correspondence: Professor E. S. Paykel. Department of Psychiatry, St George's Hospital Medical School, London
Get access Rights & Permissions [Opens in a new window]

Synopsis

A review of the literature on atypical depression indicated three relatively separate usages for the term: anxiety or phobic symptoms additional to depression, reversed functional shift, and non-endogenous depression. A sample of 160 out-patient depressives was rated on a variety of diagnostic systems measuring these concepts. Inter-relationships between groups selected by the three definitions were found to be low. In addition, although there was moderate consistency within different definitions of endogenous depression and of additional anxiety, reversed functional shift symptoms did not correlate well with each other. These findings suggest that atypical depression may be of limited value as a specific diagnosis within non-psychotic depression.

Type
Research Article
Information
Psychological Medicine , Volume 13 , Issue 1 , February 1983 , pp. 131 - 139
Copyright
Copyright © Cambridge University Press 1983

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Carney, M. W. P., Roth, M. & Garside, R. F. (1965). The diagnosis of depressive syndromes and the prediction of ECT response. British Journal of Psychiatry 111, 659–674.CrossRefGoogle Scholar
Dally, P. J. & Rohde, P. (1961). Comparison of antidepressant drugs in depressive illness. Lancet i, 18–20.CrossRefGoogle Scholar
Hempel, G. (1961). Introduction to problems of taxonomy. In Field Studies in Mental Disorders (ed. Zubin, J.), pp. 3–26. Grune & Stratton: New York.Google Scholar
Kelly, D., Guirguis, W., Frommer, E., Mitchell-Heggs, N. & Sargant, W. (1970). Treatment of phobic states with antidepressants: a retrospective study of 246 patients. British Journal of Psychiatry 116, 387–398.CrossRefGoogle ScholarPubMed
Kendell, R. E. (1968). The Classification of Depressive Illness. Maudsley Monograph No. 18. Oxford University Press: London.Google Scholar
Kendell, R. E. (1975). The Role of Diagnosis in Psychiatry. Blackwell Scientific Publications: Oxford.Google Scholar
Kiloh, L. G., Ball, J. R. B. & Garside, R. F. (1962). Prognostic factors in treatment of depressive states with imipramine. British Medical Journal i, 1225–1227.CrossRefGoogle Scholar
Klein, D. F. (1974). Endogenomorphic depression. A conceptual and terminological revision. Archives of General Psychiatry 31, 447–454.CrossRefGoogle ScholarPubMed
Mendels, J. & Cochrane, C. (1968). The nosology of depression: the endogenous-reactive concept. American Journal of Psychiatry 124, 05 Supp. 1–11.CrossRefGoogle ScholarPubMed
Paykel, E. S. (1979). Predictors of treatment response. In Psychopharmacology of Affective Disorders (ed. Paykel, E. S. and Coppen, A.), pp. 193–220. Oxford University Press: Oxford.Google Scholar
Paykel, E. S., Klerman, G. L. & Prusoff, B. A. (1970). Treatment setting and clinical depression. Archives of General Psychiatry 22, 11–21.CrossRefGoogle ScholarPubMed
Paykel, E. S., Rowan, P. R., Parker, R. R. & Bhat, A. V. (1982). Response to phenelzine and amitriptyline in sub-types of outpatient depression. Archives of General Psychiatry (In the press).CrossRefGoogle Scholar
Pollitt, J. (1965). Depression and its Treatment. Heinemann: London.Google Scholar
Pollitt, J. & Young, J. (1971). Anxiety state or masked depression? A study based on the action of monoamine oxidase inhibitors. British Journal of Psychiatry 119, 143–149.CrossRefGoogle ScholarPubMed
Quitkin, F., Rifkin, A. & Klein, D. F. (1979). Monoamine oxidase inhibitors. A review of antidepressant effectiveness. Archives of General Psychiatry 36, 749–760.CrossRefGoogle ScholarPubMed
Quiskin, F. M., Liebowitz, M. & Klein, D. F. (1982). Comparison of monoamine oxidase inhibitors and tricyclic antidepressants in the treatment of depression. In Treatment of Depression: Old Controversies and New Approaches (ed. Clayton, P. and Barrett, J.). Raven Press: New York.Google Scholar
Raskin, A., Schulterbrandt, J., Reatig, N. & MeKeon, J. (1970). Differential response to chlorpromazine, imipramine and placebo. A study of subgroups of hospitalised depressed patients. Archives of General Psychiatry 23, 164–173.CrossRefGoogle ScholarPubMed
Rassaby, E. & Paykel, E. S. (1979). Factor patterns in depression: a replication study. Journal of Affective Disorders 1, 187–194.CrossRefGoogle ScholarPubMed
Ravaris, C. L., Robinson, D. S., Ives, J. O., Nies, A. & Bartlett, D. (1980). Phenelzine and amitriptyline in the treatment of depression. Archives of General Psychiatry 37, 1075–1080.CrossRefGoogle ScholarPubMed
Robinson, D. S., Nies, A., Ravaris, C. L., Lamborn, K. R. & Burlington, V. (1973). The monoamine oxidase inhibitor, phenelzine in the treatment of depressive anxiety states. Archives of General Psychiatry 29, 407–413.CrossRefGoogle ScholarPubMed
Robinson, D. S., Nies, A., Ravaris, C. L., Ives, J. O. & Lamborn, K. R. (1974). Treatment response to MAO inhibitors. Classification and Prediction of Outcome of Depression (ed. Angst, J.), pp. 259–267. Schattauer Verlag: Stuttgart.Google Scholar
Rosenthal, S. H. & Klerman, G. L. (1966). Content and consistency in the endogenous depressive pattern. British Journal of Psychiatry 112, 471–484.CrossRefGoogle Scholar
Rowan, P. R., Paykel, E. S. & Parker, R. R. (1982). Phenelzine and amitriptyline: effects on symptoms of neurotic depression. British Journal of Psychiatry 140, 475–483.CrossRefGoogle ScholarPubMed
Spitzer, R. L., Endicott, J. & Robins, E. (1978). Research diagnostic Criteria. Archives of General Psychiatry 35, 777–782.CrossRefGoogle ScholarPubMed
Tyrer, p. (1976). Towards rational therapy with monoamine oxidase inhibitors. British Journal of Psychiatry 128, 354–360.CrossRefGoogle ScholarPubMed
Upton, J. G. G. (1978). The Analysis of Cross-Tabulated Data. John Wiley: Chichester.Google Scholar
West, E. D. & Dally, P. J. (1959). Effects of iproniazid in depressive syndromes. British Medical Journal i, 1491–1499.CrossRefGoogle Scholar